22 awards found
75A50119C00071
Department of Health and Human Services
ACAM2000, SMALLPOX (VACCINIA) VACCINE, LIVE (ACAM)
NAICS: 325414 - BIOLOGICAL PRODUCT (EXCEPT DIAGNOSTIC) MANUFACTURINGFY2025
HHSO100201600030C
Department of Health and Human Services
EO14042 EMERGENT AV7909 ANTHRAX VACCINE
NAICS: 541711 - RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGYFY2025
75A50123C00037
Department of Health and Human Services
THE PURPOSE OF THIS MODIFICATION IS TO EXERCISE AND FULLY FUND OPTION 2/CLIN0003 AND UPDATE ARTICLE B.3 ESTIMATED COST PLUS FIXED FEE CLINS.
NAICS: 541714 - RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY)FY2025
HHSO100201600030C
Department of Health and Human Services
EO14042 EMERGENT AV7909 ANTHRAX VACCINE
NAICS: 541711 - RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGYFY2025
75A50119C00071
Department of Health and Human Services
ACAM2000, SMALLPOX (VACCINIA) VACCINE, LIVE (ACAM)
NAICS: 325414 - BIOLOGICAL PRODUCT (EXCEPT DIAGNOSTIC) MANUFACTURINGFY2025
HHSO100201500004C
Department of Health and Human Services
ADVANCED DEVELOPMENT OF NUTHRAX (ANTHRAX VACCINE ABSORBED WITH CPG 7909) OR AV7909
NAICS: 541711 - RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGYFY2024
75A50123C00037
Department of Health and Human Services
THE PURPOSE OF THIS MODIFICATION IS TO EXERCISE AND FULLY FUND OPTION 1/CLIN0002 AND UPDATE ARTICLE B.3 ESTIMATED COST PLUS FIXED FEE CLINS.
NAICS: 541714 - RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY)FY2024
W81XWH19C0193
Department of Defense
$-1,138,105.82
Jul 17, 2024
ANALGESIC KETAMINE-CLINICAL TRIAL
NAICS: 541715 - RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY)FY2024
75A50119C00071
Department of Health and Human Services
ADMINISTRATIVE ACTION
NAICS: 325414 - BIOLOGICAL PRODUCT (EXCEPT DIAGNOSTIC) MANUFACTURINGFY2024
HHSO100201600030C
Department of Health and Human Services
EO14042 EMERGENT AV7909 ANTHRAX VACCINE
NAICS: 541711 - RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGYFY2024
HHSO100201600030C
Department of Health and Human Services
EO14042 EMERGENT AV7909 ANTHRAX VACCINE
NAICS: 541711 - RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGYFY2024
W81XWH19C0193
Department of Defense
$-4,200,843.37
Sep 7, 2023
ANALGESIC KETAMINE-CLINICAL TRIAL
NAICS: 541715 - RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY)FY2023
75A50123C00037
Department of Health and Human Services
MEDICAL COUNTERMEASURES (MCM) THAT CAN BE DEPLOYED IN THE EVENT OF A FILOVIRUS OUTBREAK ARE A CRUCIAL COMPONENT TO THE UNITED STATES GOVERNMENT?S (USG?S) OUTBREAK RESPONSE PLAN. BIOMEDICAL ADVANCED RESEARCH AND DEVELOPMENT AUTHORITY (BARDA) IS SEEKIN
NAICS: 541714 - RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY)FY2023
HHSO100201600030C
Department of Health and Human Services
EO14042 EMERGENT AV7909 ANTHRAX VACCINE
NAICS: 541711 - RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGYFY2023
75A50119C00071
Department of Health and Human Services
ADMINISTRATIVE ACTION
NAICS: 325414 - BIOLOGICAL PRODUCT (EXCEPT DIAGNOSTIC) MANUFACTURINGFY2023
75A50119C00071
Department of Health and Human Services
ADMINISTRATIVE ACTION
NAICS: 325414 - BIOLOGICAL PRODUCT (EXCEPT DIAGNOSTIC) MANUFACTURINGFY2023
W81XWH19C0193
Department of Defense
$-6,787,811.64
Mar 31, 2023
ANALGESIC KETAMINE-CLINICAL TRIAL
NAICS: 541715 - RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY)FY2023
HHSO100201600030C
Department of Health and Human Services
EO14042 EMERGENT AV7909 ANTHRAX VACCINE
NAICS: 541711 - RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGYFY2023
HHSN272201400038C
Department of Health and Human Services
DEVELOPMENT OF VACCINE FORMULATIONS EFFECTIVE AGAINST NIAID PRIORITY PATHOGENS
NAICS: 541712 - RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT BIOTECHNOLOGY)FY2023
W81XWH19C0193
Department of Defense
ANALGESIC KETAMINE-CLINICAL TRIAL
NAICS: 541715 - RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY)FY2023
HHSO100201700001C
Department of Health and Human Services
ADD ADDITIONAL FUNDING TO CLIN 0003 AND EXTEND POP TO 4/30/24
NAICS: 541711 - RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGYFY2022
HHSN272201400038C
Department of Health and Human Services
DEVELOPMENT OF VACCINE FORMULATIONS EFFECTIVE AGAINST NIAID PRIORITY PATHOGENS
NAICS: 541712 - RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT BIOTECHNOLOGY)FY2022